首页> 外文期刊>Japanese heart journal >Effect of Prolonged Prazosin Treatment on Hemodynamic and Biochemical Changes in the Dog Heart Due to Chronic Pressure Overload
【24h】

Effect of Prolonged Prazosin Treatment on Hemodynamic and Biochemical Changes in the Dog Heart Due to Chronic Pressure Overload

机译:长期使用哌唑嗪对慢性压力超负荷引起的犬心脏血流动力学和生化变化的影响

获取原文
获取外文期刊封面目录资料

摘要

A decrease in cardiac function and intracellular calcium, and an increase in cardiac sarcolemmal ATPase have been reported in experimentally induced aortic stenosis of 6 to 9 months duration. Prazosin has been used in the treatment of heart failure due to mechanical ventricular overload. It is, however, not known whether prazosin treatment gives only hemodynamic benefit with accompanying subjective improvement or if it also improves the condition of the myocardium in terms of contractility and biochemical changes. The present investigation deals with the effects of 3 months of prazosin treatment on cardiac function, electrolytes, and ATPase in dogs with aortic stenosis of 3 months duration. Although there were no significant changes in most of the left and right ventricular hemodynamic parameters, the left ventricular enddiastolic pressure increased significantly after 3 months of aortic stenosis. Prazosin prevented further deterioration of cardiac function. All the dogs developed left ventricular hypertrophy and all chest X-rays showed cardiomegaly. Concomitant with these changes, there was a tendency towards a decrease in total tissue Ca++ and intracellular Ca++ and K+ and a tendency towards an increase in sarcolemmal Na+-K+-ATPase. Prazosin treatment, although it markedly reduced left ventricular end-diastolic pressure, did not reduce the cardiomegaly. There were no significant changes in any of the other hemodynamic parameters. Prazosin treatment decreased sarcolemmal ATPase and tended to increase intracellular Ca++. It appears therefore that prazosin not only tends to bring the cardiac function towards control values but also tends to correct the ATPase and intracellular Ca++ levels of the failing heart.
机译:据报道,在实验诱导的主动脉瓣狭窄持续6到9个月的过程中,心脏功能和细胞内钙的减少以及心肌肌膜ATPase的增加。哌唑嗪已用于治疗由于机械性心室超负荷引起的心力衰竭。然而,就收缩性和生化改变而言,不知道吡唑嗪治疗是否仅带来血液动力学益处并伴随主观改善,或者是否还改善了心肌状况。本研究涉及3个月的哌唑嗪治疗对3个月持续时间的主动脉狭窄犬的心脏功能,电解质和ATPase的影响。尽管大多数左心室和右心室血流动力学参数没有显着变化,但在主动脉狭窄3个月后,左心室舒张压明显增加。哌唑嗪防止心脏功能进一步恶化。所有的狗都发展为左心室肥大,所有的胸部X光片显示心脏肥大。伴随这些变化,存在总组织Ca ++和细胞内Ca ++和K +减少的趋势,以及肌膜Na + -K + -ATPase增加的趋势。哌唑嗪治疗虽然可以明显降低左心室舒张末期压力,但并不能减轻心脏肥大。其他血液动力学参数均无明显变化。吡唑嗪治疗可减少肌膜ATPase并增加细胞内Ca ++。因此看来,哌唑嗪不仅趋于使心脏功能达到控制值,而且趋于纠正衰竭心脏的ATP酶和细胞内Ca ++水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号